paclitaxel has been researched along with Deafness, Transitory in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Casale, M; Di Peco, V; Firrisi, L; Greco, F; Onori, N; Salvinelli, F; Santini, D; Tonini, G; Vincenzi, B | 1 |
1 other study(ies) available for paclitaxel and Deafness, Transitory
Article | Year |
---|---|
Bilateral irreversible hearing loss associated with the combination of carboplatin and paclitaxel chemotherapy: a unusual side effect.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Audiometry; Carboplatin; Female; Hearing Loss; Humans; Neoplasm Staging; Ovarian Neoplasms; Paclitaxel; Time Factors; Treatment Outcome | 2003 |